January 2023 in “Revista Eletrônica Acervo Saúde” This review reports that post-COVID telogen effluvium may be influenced by immune and psychological factors linked to COVID-19 infection, affecting hair loss.
March 2022 in “Brazilian Journal of Health Review” This study suggests that COVID-19 infection can lead to telogen effluvium, typically occurring 3-6 months post-infection, potentially linked to the virus's inflammatory and anticoagulation effects.
October 2022 in “Research, Society and Development” This review discusses the complex nature of telogen effluvium linked to COVID-19 and highlights the effectiveness of correcting triggers and protein-rich diets in reducing hair loss; it reports no new clinical findings.
September 2023 in “Brazilian Journal of Health Review” This study's systematic review found that many individuals recovering from COVID-19 experience high rates of telogen effluvium, a common form of hair loss, highlighting limited epidemiological data and the need for further investigation into this condition post-COVID-19.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study explored the potential link between an increase in telogen effluvium cases and COVID-19, suggesting that the infection's trigger factors may directly influence this hair loss condition, underscoring the need for effective treatment strategies.